Top Markets
#1 DogBull DogBull +49.01%
#2 Siren Siren +29.76%
#3 OriginTrail OriginTrail +21.49%
#4 MarsCoin MarsCoin +14.53%
#5 Verus Coin Verus Coin +7.09%
#6 Xphere Xphere +5.99%
#7 COTI COTI +5.94%
#8 PulseChain PulseChain +5.89%
#9 Concordium Concordium +5.86%
#10 Pons Pons +5.55%
Coin of the day
DogBull DogBull
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Wuhan YZY Biopharma Co Ltd Wuhan YZY Biopharma Co Ltd

Wuhan YZY Biopharma Co Ltd

2496
Hisse Senetlerindeki Sıralama #22213
Wuhan YZY Biopharma Co., Ltd. is a biotechnology enterprise specializing in the... Wuhan YZY Biopharma Co., Ltd. is a biotechnology enterprise specializing in the development of bispecific antibody-based treatments. Its therapeutic focus areas include various cancers, their associated complications, and age-related ophthalmic conditions. The company's extensive portfolio of drug candidates aims to address a wide range of diseases, such as malignant ascites, malignant pleural effusion, various solid tumors (including pancreatic cancer, hepatocellular carcinoma, other advanced solid tumors, and HER2-positive solid tumors), small cell lung cancer, and relapsed/refractory multiple myeloma. Additionally, they are advancing therapies for COVID-19 and several eye disorders like wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and other conditions characterized by abnormal blood vessel formation in the eye. The company, established in 2010, is headquartered in Wuhan, China.
Hisse Fiyatı
$0.46053443
Son senkronizasyon: 2026-08-13
Piyasa Değeri
$92.44M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
-36.86%
Ülke
CN
Ticaret Wuhan YZY Biopharma Co Ltd (2496)

Kategori

Healthcare
Wuhan YZY Biopharma Co Ltd (2496) için kazanç
2026 itibarıyla kazanç TTM: 0
Wuhan YZY Biopharma Co Ltd şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Wuhan YZY Biopharma Co Ltd için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH